| CurveBeam AI Limited (CVB) ORDINARY FULLY PAID |
Health Care |
$42 |
Application for quotation of securities - CVB
|
31 Oct 2024 9:12AM |
$0.110 |
$0.130 |
risen by
18.18%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,348 |
Karoon Field Trip Presentation
|
31 Oct 2024 9:12AM |
$1.370 |
$1.840 |
risen by
34.31%
|
|
| Ovanti Limited (OVT) ORDINARY FULLY PAID |
Communication Services |
$38 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2024 9:12AM |
$0.030 |
$0.009 |
fallen by
70%
|
|
OVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Ovanti Limited reported a negative cash flow of AUD 1,634K for the quarter.
- The company's cash reserves stand at AUD 368K as of 30 September 2024.
- Ovanti plans to sell its 21% stake in IDSB to fund entry into the US BNPL market.
- Monthly dividends from IDSB increased by 57% to RM 369,000.
- iSentric renewed a three-year contract with Bank Simpanan Nasional Malaysia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Parabellum Resources Limited (PBL) ORDINARY FULLY PAID |
Materials |
$3 |
Initial Director's Interest Notice
|
31 Oct 2024 9:11AM |
$0.049 |
$0.056 |
risen by
14.29%
|
|
| Aurum Resource Limited (AUE) ORDINARY FULLY PAID |
Materials |
$194 |
Hong Kong Non-Deal Roadshow
|
31 Oct 2024 9:11AM |
$0.495 |
$0.570 |
risen by
15.15%
|
|
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$204 |
Update - Notification of buy-back - CDM
|
31 Oct 2024 9:11AM |
$0.690 |
$0.685 |
fallen by
0.72%
|
|
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$2,963 |
Q1, FY25 Investor Update and Webcast
|
31 Oct 2024 9:11AM |
$3.230 |
$3.140 |
fallen by
2.79%
|
|
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$66 |
LRT Security Purchase Plan - Unitholder Letter
|
31 Oct 2024 9:11AM |
$1.170 |
$1.570 |
risen by
34.19%
|
|
| Parabellum Resources Limited (PBL) ORDINARY FULLY PAID |
Materials |
$3 |
Final Director's Interest Notice x2
|
31 Oct 2024 9:11AM |
$0.049 |
$0.056 |
risen by
14.29%
|
|
| Navigator Global Investments Limited (NGI) FPO-U.S. INVESTOR PROHIBITED EXCEPT QPS |
Financials |
$1,014 |
AGM Presentation
|
31 Oct 2024 9:10AM |
$1.690 |
$2.070 |
risen by
22.49%
|
|
NGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Adjusted EBITDA increased by 85% year-on-year.
- Revenue grew by 46% on a year-on-year basis.
- New CEO appointed to enhance market engagement.
- Strong operating cash flow supports future investments.
- Significant progress made in managing liabilities.
- NGI positioned for strong growth amidst challenging fundraising environment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$79 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2024 9:10AM |
$0.047 |
$0.275 |
risen by
485.11%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Three complete responses achieved in the azer-cel Phase 1b trial for DLBCL
- Trial will continue enrolling patients in cohort B with plans to use findings for a potential FDA Phase 2 trial for azer-cel
- FDA Orphan Drug Designation received for VAXINIA to treat bile tract cancer
- First patient dosed in Phase 1 bile tract cancer expansion trial at St. Vincent's Hospital, Melbourne
- Cash position of $54.3 million as at 30 September 2024
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Navigator Global Investments Limited (NGI) FPO-U.S. INVESTOR PROHIBITED EXCEPT QPS |
Financials |
$1,014 |
AGM Chair and CEO Address
|
31 Oct 2024 9:10AM |
$1.690 |
$2.070 |
risen by
22.49%
|
|
NGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Record Adjusted EBITDA of US$90.5 million for FY24, up 85% year-on-year.
- Completion of the acquisition of all remaining interests in strategic managers two and a half years ahead of schedule.
- Significant distribution income of $34.3 million from the NGI Strategic Portfolio.
- AUM increased by 3% to USD 26.2 billion driven by strong investment performance.
- Revenue grew by 46% to USD 172.3 million.
- The company remains focused on expanding its portfolio of partner firms.
- NGI's business model reflects resilience through diversified strategies and consistent performance fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alara Resources Limited (AUQ) ORDINARY FULLY PAID |
Materials |
$32 |
Omani Ministry of Energy and Minerals visits Wash-hi Mine
|
31 Oct 2024 9:09AM |
$0.046 |
$0.040 |
fallen by
13.04%
|
|
| Emerald Resources NL (EMR) ORDINARY FULLY PAID |
Materials |
$2,342 |
Quarterly Report
|
31 Oct 2024 9:09AM |
$4.190 |
$3.550 |
fallen by
15.27%
|
|
EMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Gold production of 28,046 ounces at Okvau Gold Mine.
- AISC of US$991 per ounce for the quarter.
- Pre-tax operating cash flow of A$57.8 million.
- Gold sales averaged US$2,496 per ounce.
- Cash and bullion on hand reached A$180.8 million.
- Tenth tonne of gold poured at Okvau Gold Mine.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Green Technology Metals Limited (GT1) ORDINARY FULLY PAID |
Materials |
$18 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2024 9:09AM |
$0.090 |
$0.037 |
fallen by
58.89%
|
|
GT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Executed a Corporate Investment Subscription of A$8,000,000 with EcoPro Innovation.
- Received conditional government funding of up to C$5,470,000 for the Seymour Project.
- Appointed new Project Development lead to oversee Pre-Feasibility Study.
- Exploration success at Junior Lithium Project with new high-grade lithium zones discovered.
- Completed diamond drilling program at Seymour with assays pending.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| East 33 Limited (E33) ORDINARY FULLY PAID |
Consumer Staple |
- |
Change in substantial holding
|
31 Oct 2024 9:09AM |
$0.023 |
$0.022 |
fallen by
2.22%
|
|
| East 33 Limited (E33) ORDINARY FULLY PAID |
Consumer Staple |
- |
Change in substantial holding
|
31 Oct 2024 9:09AM |
$0.023 |
$0.022 |
fallen by
2.22%
|
|
| Arizona Lithium Limited (AZL) ORDINARY FULLY PAID |
Materials |
$43 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2024 9:08AM |
$0.016 |
$0.008 |
fallen by
50%
|
|
AZL - Price-sensitive ASX Announcement
Full Release
Key Points
- Produced battery grade lithium carbonate from the Prairie Project.
- Received conditional approval for $21.6 million in transferable royalty credits under the OPGII Program.
- Discovered new lithium-enriched formations in the Souris River and Dawson Bay Formations.
- Commenced drilling Well #3 at Pad #1 at the Prairie Project.
- Completed bulk sampling at the Big Sandy Lithium Project.
- Received approval from the US Bureau of Land Management for exploration drilling at the Big Sandy Project.
- Drilling operations planned to continue at Pad #2 and Pad #3.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$2 |
Activities Report September 2024 and Appendix 4C
|
31 Oct 2024 9:08AM |
$0.041 |
$0.010 |
fallen by
75.61%
|
|
OSX - Price-sensitive ASX Announcement
Full Release
Key Points
- Osteopore achieved 29% YoY revenue growth in Q3 CY24.
- The company signed an exclusive distribution agreement with Zimmer Biomet.
- Dr. Yujing Lim was appointed Executive Director.
- Osteopore and the University of Chile completed pre-clinical bone implant studies.
- The company plans to raise A$20 million via redeemable convertible notes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$2,963 |
September 2024 Quarterly Results
|
31 Oct 2024 9:07AM |
$3.230 |
$3.140 |
fallen by
2.79%
|
|
WGX - Price-sensitive ASX Announcement
Full Release
Key Points
- Westgold produced 77,369 ounces of gold in Q1 FY25.
- The All-In Sustaining Cost (AISC) for the quarter was $2,422 per ounce.
- Net mine cash flow for Q1 FY25 was $29 million.
- The company achieved a record gold price of $3,723 per ounce.
- Westgold is unhedged and fully leveraged to the gold price.
- The merger with Karora Resources has transformed Westgold into a top five Australian gold producer.
- The company aims to produce 400,000 to 420,000 ounces in FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$66 |
Share Purchase Plan Offer Booklet
|
31 Oct 2024 9:07AM |
$1.170 |
$1.570 |
risen by
34.19%
|
|
| Victor Group Holdings Limited (VIG) ORDINARY FULLY PAID |
Information Technology |
$27 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2024 9:07AM |
$0.053 |
$0.041 |
fallen by
22.64%
|
|
VIG - Price-sensitive ASX Announcement
Full Release
Key Points
- VIG operates cloud services through its subsidiary Shenghan in PRC.
- Collected around $2.96 million in trade receivables during the quarter.
- IaaS, SaaS, and PaaS services contributed $2.86 million in cash inflow.
- The company did not achieve a positive operating cash flow this quarter.
- Cash and cash equivalents position at $550K, down $782K from the last quarter.
- The management believes external fundraising is unnecessary at this stage.
- E-learning collaborations are ongoing under new K12 education regulations.
- Total reported revenue was $2.96 million, with expenditures totaling $4.65 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lake Resources NL (LKE) ORDINARY FULLY PAID |
Materials |
$72 |
Notification regarding unquoted securities - LKE
|
31 Oct 2024 9:07AM |
$0.062 |
$0.038 |
fallen by
38.71%
|
|
| Dotz Nano Limited (DTZ) ORDINARY FULLY PAID |
Information Technology |
$22 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2024 9:07AM |
$0.080 |
$0.037 |
fallen by
53.75%
|
|
DTZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful lab-scale pilot demonstration of DotzEarth technology.
- Development of a new sorbent for direct air capture emissions.
- Raised AU$2.2 million via private placement to support DotzEarth development.
- Commenced trading on the OTCQB Market in the U.S.
- Conducted a non-deal roadshow in the U.S. with positive feedback.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$268 |
Quarterly Activity Report and Appendix 4C for Q1 FY2025
|
31 Oct 2024 9:06AM |
$0.510 |
$0.575 |
risen by
12.75%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- 4DMedical signed a critical reseller agreement with Philips.
- The agreement enhances 4DMedical's technology delivery to U.S. government clients.
- 4DMedical reported a 366% increase in operating revenue for Q1 FY2025.
- The company anticipates FDA clearance for its CT:VQ product in 2025.
- 4DMedical aims to support veterans with respiratory issues through its advanced technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
